medical sample 13

9
Heparan sulfate Endothelial cell B-lymphocyte Heparin Resting platelet PF4 Activated platelet Microparticles Monocyte Endothelial cell activation HIT antibody Tissue factor Thrombin Fibrinogen Fc receptor GpIIb/ IIIa Pathogenesis of HIT

Upload: skyecreative

Post on 17-Jan-2015

479 views

Category:

Health & Medicine


3 download

DESCRIPTION

 

TRANSCRIPT

Page 1: Medical Sample 13

Heparan sulfate

Endothelial cell

B-lymphocyte Heparin

Resting platelet

PF4

Activated platelet

Microparticles

Monocyte

End

othe

lial c

ell a

ctiv

atio

n

HIT antibody

Tissue factor

Thrombin

Fibrinogen

Fc receptor

GpIIb/ IIIa

Pathogenesis of HIT

Page 2: Medical Sample 13

Platelet Activation in HIT

Resting Platelet HIT-activated Platelet

Procoagulant, platelet-derived microparticles

Page 3: Medical Sample 13

Heparin/PF4 Complex

HIT-IgG

Radiolabeled serotonin released from platelets

Schematic Figure of the Serotonin Release Assay (platelet activation assay)

Page 4: Medical Sample 13

Patient serum or plasma is added to microtiter plates coated with PF4 and heparin

heparin

PF4PF4/heparincomplex

HIT-IgG(from serum or plasma)

Add substrate COLOR

Alkaline phosphatase-conjugated goat antihuman IgG

Add alkaline phosphatase-conjugated goat antihuman IgG

wash wash

Schematic Figure of Solid-phase PF4/Heparin-EIA (immunoassay)

Page 5: Medical Sample 13

Clinical Features of HIT

1%-3% with 1-2 weeks of unfractionatedheparin (UFH) prophylaxis post-surgery

Incidence of HIT

Thromboembolic events: venous > arterialComplications

Median time to platelet count >150 = 4 days (90% by 1 week)

Platelet count recovery

Typically 20-150 x 109/L• Median platelet count nadir ~ 60• Sometimes, platelet count falls by >50%, but

remains >150

Platelet count nadir

Typically 5-10 days after starting heparin (<1 day if recent heparin exposure)

Onset

Page 6: Medical Sample 13

Num

ber

of P

atie

nts

With

HIT

0

10

20

30

40

10 100 1000 3 20 30 50 70 150 15 5 300 500 200

Platelet Count Nadir (x 109/L)

Median platelet count nadir ≈ 60 x 109/L

No HIT-associatedthrombosis

HIT-associatedthrombosis

Standard definitionof thrombocytopenia

(150 x 109/L)

Thrombosis Is Common in HIT

Page 7: Medical Sample 13

Economic Consequences of HIT

• A cost analysis model suggests a range of $38,046 to $52,164 estimated mean hospital cost per patient having HIT

*

Page 8: Medical Sample 13

**

9 Patients With HIT Post-Orthopedic Surgery

day 17

0

200 Pla

tele

t C

ount

x 1

09/L

Pre 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Postoperative Day

400

600

800

1000

Mean

+2 SD

-2 SD

PE

PE

PE

Patients with HIT (n=9)

Bilateral lower-limb DVTArterial clot

Unilateral lower-limb DVT

Pulmonary embolism

Normal Postoperative Platelet Counts(mean + 2 SD)

*

******

* **

*

PE

PE

A

A

Page 9: Medical Sample 13

0

200

Pla

tele

t C

ount

x 1

09/L

Pre 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Postoperative Day

400

600

800

1000

Mean

+2 SD

-2 SD

Normal Postoperative Platelet Counts(mean + 2 SD)

UFH, n=7LMWH, n=2

150 x 109/L (standard definition of thrombocytopenia)

**

*

*

*

*DVT

HIT Complicating Orthopedic Surgery: Platelet Fall >50% Day 4 to 14